Pharma

Latest posts

Our NHS at 70 is still amazing. Why isn't there an NHS for the world?


05 July 2018

The National Health Service turns 70 today. Despite too many years of austerity cuts, contracting out and PFIs, most of us still feel the NHS is one of the defining achievements of our society.

Trump: “put American patients first” … but er, after big business


30 May 2018

The Trump administration has promised to use American muscle in trade negotiations to force health services, including the NHS, to pay much more for drugs to American corporations. They are putting big business first, not patients.

Five reasons Sturgeon should stand up to Big Pharma


24 May 2018

The high price of breast cancer drug Perjeta means it is not currently available to patients in Scotland, but is available in England and Wales. How do we make sure essential medicines are affordable for everyone in the UK?

Latest news

Global protests ahead of Novartis AGM in Switzerland tomorrow. Call for new CEO to clean up company following scandals in Colombia and Greece.

Campaign groups Global Justice Now and STOPAIDS have welcomed a statement by NHS England to the BBC’s 5 Live Investigates this morning that “further regulatory action may be needed” on drug pricing at a time when NHS funding is under severe pressure.

Treatments for cancer, arthritis and multiple sclerosis (MS) are among drugs costing the cash-strapped NHS over a billion pounds a year – despite public funding playing a substantial role in the medicines’ development.

Resources

Pharma - NHS birthday A5 leaflet

May 2018

As the NHS turns 70, it is locked in a crisis of underfunding. The reasons are many, from government funding cuts to the massive debts racked up as a result of Private Finance Initiatives. But one factor that gets less notice is the rip-off prices the pharmaceutical industry charges for a huge range of drugs.

Resource thumbail

Pharmaceutical campaign: activist lobby guide

March 2018

This briefing provides the key talking points that you can use in a meeting with your MP about our campaign for affordable medicines. The briefing is intended to help you lobby:

- An MP who has not taken action on this campaign

- An MP who has taken action on this campaign or

-An MP that is a member of the business, health or public accounts committees

Please use the lobbying advice that is most relevant to your MP.

Resource thumbail

Pills and profit: MP briefing

February 2018

This briefing for MPs and parliamentarians documents examples of where publicly funded research and development has led to drugs that the public have found difficult to access. It calls for conditions to be attached to public research to ensure drugs are affordable for all patients.